Because you can get back to the things that matter.
RUCONEST can give you the HAE symptom relief you need – when you need it. RUCONEST is a C1 esterase inhibitor, or C1-INH, indicated for the treatment of acute attacks in adult and adolescent patients with HAE. It replaces the missing or nonworking C1-INH to stop an HAE swell before it fully develops.
Patients self-reported 1301 swells*
On average, patients reported 2.1 locations per swell
Over half of swells reported by patients were in the stomach/abdomen
Patients also reported experiencing swells in other body locations
*Survey Data on File: June 2020 to August 2021, 1301 swells were reported from 131 patients
Re-treating swells can be high with some HAE treatments
*Based on literature, 3-44% of swells needed to be retreated
Track swells with HAE & Me App
Accurately track your triggers, swells, and treatment habits.
The HAE & Me App provides one place to document your HAE swells and easily share with your doctor. It's free and easy to use.
Experience the benefits of one-and-done dosing with RUCONEST
If you are treating the same swell multiple times, speak to your doctor about a change. RUCONEST may be able to help you get back to things that matter. RUCONEST replaces the missing or nonworking C1-INH to stop an HAE swell.
9 of 10 patients achieved symptom relief in the pivotal clinical trial with just 1 dose (n=44)*
In the primary clinical study, patients saw symptom relief in 90 minutes vs 152 minutes with placebo*
In the extension study, symptom relief began in 75 minutes*
Your acute medication should work with just 1 dose and provide you relief that lasts.
*As shown in a review of studies that included 68 people (280 attacks). Based on a post hoc analysis of pooled data from the randomized controlled study and open-label extension phases of 2 studies involving 127 patients aged ≥ 13 years who were treated with RUCONEST 50 U/kg (max 4200 U) for acute attacks of HAE. Data for 72 hours were available for 68 of 127 patients.
RUCONEST has a well-established tolerability profile
RUCONEST has a well-established tolerability profile. Adverse reactions in ≥2% of patients in 7 studies (all RUCONEST doses up to 100 U/kg) included:
Headache9% (19 of 205 patients)
Nausea2% (5 of 205 patients)
Diarrhea2% (5 of 205 patients)
Just one dose of RUCONEST can get you back to things that matter
97%One and Done – 97% of acute swells were treated with JUST 1 DOSE*
93%Relief That Lasts – Stopped 93% of attacks for at least 3 days†
85%Confident Dosing – 85% of patients were confident self-administering‡
How RUCONEST is helping Sophie manage her swells
*50 U/kg (max 4200 U) in clinical studies (open-label extension phase, n=44 [170 attacks]). †As shown in a review of studies that included 68 people (280 attacks). ‡Data from 601 patients using RUCONEST show that 85% of patients trained felt confident, mostly confident, or extremely confident on a Likert scale of 1-5 in terms of their ability to self-infuse.
Track your symptoms with the HAE & Me App
The HAE & Me app provides free tools to help you stay informed and track your swells.
Use the app to accurately track your triggers, swells, and treatment habits.
Remember, even if you are on a preventative treatment, many people with HAE may still experience breakthrough swells and it’s important to share these experiences with your doctor.
The app creates a comprehensive report you can email to your doctor.
Accurately documenting your HAE experience and communicating with your doctor can help ensure you have the right treatment plan for you.
Other app resources include inspirational messages, HAE education, and private medical document storage.
Feel empowered
Knowledge is power! Stay informed on the latest in treatment, support, and more.
Some insurance companies are instituting new policies called accumulator adjustment programs and/or maximizer programs. These can affect your participation in the RUCONEST Patient Savings Program.
Accumulator Adjustment Programs are when your insurance plan does not apply the RUCONEST Patient Savings Program to satisfy your co-payment, deductible, or co-insurance for RUCONEST.
Co-pay Maximizer Programs are when your insurance company requires you to enroll in the RUCONEST Patient Savings Program as a condition of your plan or to waive other costs associated with the insurance plan.
If your plan has these limitations, you will not be eligible for the RUCONEST Patient Savings Program, but you may be eligible for other external needs-based assistance programs. Please contact RUCONEST SOLUTIONS for additional information.
If you have any questions, our team of experts is available to provide assistance. Our priority is your well-being. Please call RUCONEST SOLUTIONS for more information at 1-855-613-4HAE (4423).
